JP2019517996A5 - - Google Patents

Download PDF

Info

Publication number
JP2019517996A5
JP2019517996A5 JP2018550733A JP2018550733A JP2019517996A5 JP 2019517996 A5 JP2019517996 A5 JP 2019517996A5 JP 2018550733 A JP2018550733 A JP 2018550733A JP 2018550733 A JP2018550733 A JP 2018550733A JP 2019517996 A5 JP2019517996 A5 JP 2019517996A5
Authority
JP
Japan
Prior art keywords
methyl
pyrazolo
pyridin
tetrahydropyran
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018550733A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019517996A (ja
JP7093306B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/058332 external-priority patent/WO2017178350A1/en
Publication of JP2019517996A publication Critical patent/JP2019517996A/ja
Publication of JP2019517996A5 publication Critical patent/JP2019517996A5/ja
Application granted granted Critical
Publication of JP7093306B2 publication Critical patent/JP7093306B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018550733A 2016-04-12 2017-04-07 ＰＤＥ１阻害剤としての１，５－ジヒドロ－４Ｈ－ピラゾロ［３，４－ｄ］ピリミジン－４－オン及び１，５－ジヒドロ－４Ｈ－ピラゾロ［４，３－ｃ］ピリジン－４－オン Expired - Fee Related JP7093306B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201600221 2016-04-12
DKPA201600221 2016-04-12
PCT/EP2017/058332 WO2017178350A1 (en) 2016-04-12 2017-04-07 1,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4h-pyrazolo[4,3-c]pyridin-4-ones as pde1 inhibitors

Publications (3)

Publication Number Publication Date
JP2019517996A JP2019517996A (ja) 2019-06-27
JP2019517996A5 true JP2019517996A5 (https=) 2020-05-07
JP7093306B2 JP7093306B2 (ja) 2022-06-29

Family

ID=58489694

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018550733A Expired - Fee Related JP7093306B2 (ja) 2016-04-12 2017-04-07 ＰＤＥ１阻害剤としての１，５－ジヒドロ－４Ｈ－ピラゾロ［３，４－ｄ］ピリミジン－４－オン及び１，５－ジヒドロ－４Ｈ－ピラゾロ［４，３－ｃ］ピリジン－４－オン

Country Status (43)

Country Link
US (3) US20170291901A1 (https=)
EP (1) EP3442975B1 (https=)
JP (1) JP7093306B2 (https=)
KR (1) KR20180133413A (https=)
CN (1) CN109071549B (https=)
AR (1) AR108109A1 (https=)
AU (1) AU2017250431B2 (https=)
BR (1) BR112017026278A2 (https=)
CA (1) CA3020053A1 (https=)
CL (1) CL2018002881A1 (https=)
CO (1) CO2018010323A2 (https=)
CR (1) CR20180470A (https=)
CY (1) CY1123269T1 (https=)
DK (1) DK3442975T3 (https=)
DO (1) DOP2018000201A (https=)
EA (1) EA035197B1 (https=)
EC (1) ECSP18074641A (https=)
ES (1) ES2814289T3 (https=)
GE (2) GEAP201914901A (https=)
HR (1) HRP20201331T1 (https=)
HU (1) HUE050320T2 (https=)
IL (1) IL262257B (https=)
LT (1) LT3442975T (https=)
MA (1) MA44656B1 (https=)
ME (1) ME03820B (https=)
MX (1) MX374251B (https=)
MY (1) MY194722A (https=)
NI (1) NI201800092A (https=)
PE (1) PE20181853A1 (https=)
PH (1) PH12018502168A1 (https=)
PL (1) PL3442975T3 (https=)
PT (1) PT3442975T (https=)
RS (1) RS60714B1 (https=)
RU (1) RU2018133391A (https=)
SG (1) SG11201808221QA (https=)
SI (1) SI3442975T1 (https=)
SM (1) SMT202000446T1 (https=)
SV (1) SV2018005753A (https=)
TN (1) TN2018000321A1 (https=)
TW (1) TWI729109B (https=)
UA (1) UA121925C2 (https=)
WO (1) WO2017178350A1 (https=)
ZA (1) ZA201806407B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201629064A (zh) 2014-10-10 2016-08-16 Ｈ 朗德貝克公司 作爲ｐｄｅ１抑制劑之三唑並吡酮
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商Ｈ 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
WO2018073251A1 (en) 2016-10-18 2018-04-26 H. Lundbeck A/S Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as pde1 inhibitors
WO2018078042A1 (en) 2016-10-28 2018-05-03 H. Lundbeck A/S Combination treatments comprising administration of imidazopyrazinones
AU2017350473A1 (en) 2016-10-28 2019-04-18 H. Lundbeck A/S Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders
KR102590848B1 (ko) 2016-12-28 2023-10-19 다트 뉴로사이언스, 엘엘씨 Pde2 억제제로서 치환된 피라졸로피리미디논 화합물
DK3717488T3 (da) * 2017-11-27 2021-12-13 Dart Neuroscience Llc Substituerede furanopyrimidinforbindelser som pde1-inhibitorer
MX2020012628A (es) 2018-05-25 2021-01-29 Intra Cellular Therapies Inc Compuestos organicos.
WO2020210614A1 (en) 2019-04-12 2020-10-15 Intra-Cellular Therapies, Inc. Organic compounds
CN115304607B (zh) * 2022-07-06 2023-06-27 华南农业大学 吡唑并嘧啶衍生物的制备方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB973361A (en) * 1960-05-11 1964-10-28 Ciba Ltd Pyrazolo-pyrimidines and process for their manufacture
DE19709877A1 (de) 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
DE10238723A1 (de) * 2002-08-23 2004-03-11 Bayer Ag Phenyl-substituierte Pyrazolyprimidine
DE10238722A1 (de) * 2002-08-23 2004-03-11 Bayer Ag Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
DE10238724A1 (de) * 2002-08-23 2004-03-04 Bayer Ag Alkyl-substituierte Pyrazolpyrimidine
WO2004099211A1 (de) * 2003-05-09 2004-11-18 Bayer Healthcare Ag 6-cyclylmethyl- und 6-alkylmethyl-substituierte pyrazolopyrimidine
JP2008524331A (ja) 2004-12-21 2008-07-10 武田薬品工業株式会社 ジペプチジルペプチダーゼ阻害剤
US20080194592A1 (en) 2005-08-23 2008-08-14 Intra-Cellular Therapies, Inc. Organic Compounds
US8012936B2 (en) 2006-03-29 2011-09-06 New York University Tau fragments for immunotherapy
WO2008070095A1 (en) 2006-12-05 2008-06-12 Intra-Cellular Therapies, Inc. Novel uses
RS52166B (sr) * 2007-05-11 2012-08-31 Pfizer Inc. Amino-heterociklična jedinjenja
EP2227472A1 (en) 2007-11-30 2010-09-15 Elbion Gmbh Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
KR20110063447A (ko) 2008-09-08 2011-06-10 베링거 인겔하임 인터내셔날 게엠베하 피라졸로피리미딘 및 ｃｎｓ 장애의 치료를 위한 이들의 용도
EP2367430B1 (en) 2008-12-06 2014-08-13 Intra-Cellular Therapies, Inc. Organic compounds
TWI404721B (zh) 2009-01-26 2013-08-11 Pfizer 胺基－雜環化合物
WO2011153136A1 (en) * 2010-05-31 2011-12-08 Intra-Cellular Therapies, Inc. Organic compounds
EP2619208B1 (en) 2010-09-20 2016-11-09 Ironwood Pharmaceuticals, Inc. Imidazotriazinone compounds
EP2619204A4 (en) 2010-09-21 2014-08-27 Merck Sharp & Dohme TRIAZOLOPYRAZINONE AS P2X7 RECEPTOR ANTAGONISTS
JO3089B1 (ar) 2010-11-19 2017-03-15 H Lundbeck As مشتقات ايميدازول كمثبطات لانزيمات pde10a
US9499610B2 (en) 2011-04-08 2016-11-22 H. Lundbeck A/S Antibodies specific to pyroglutamated Aβ
JP6051210B2 (ja) 2011-06-10 2016-12-27 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
BR112015007731B1 (pt) 2011-10-10 2022-05-31 H. Lundbeck A/S Composto, composição farmacêutica que o compreende e uso do mesmo
BR112014018199A8 (pt) 2012-01-26 2021-03-02 H Lundbeck As inibidores da pde9 com cadeia principal imidazo triazinona, composição farmacêutica que os compreende, uso dos referidos inibidores e processo para sua preparação
CA2877146C (en) 2012-06-18 2020-10-20 Dart Neuroscience (Cayman) Ltd Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds
KR102240326B1 (ko) 2013-03-15 2021-04-13 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
JP5783297B2 (ja) 2013-08-06 2015-09-24 株式会社デンソー 力学量センサ
TW201609713A (zh) * 2013-12-19 2016-03-16 Ｈ 朗德貝克公司 作爲ｐｄｅ１抑制劑之喹唑啉－ｔｈｆ－胺
JP5797815B1 (ja) 2014-06-27 2015-10-21 細田建設株式会社 後施工アンカー及びその施工方法
WO2016042775A1 (en) 2014-09-18 2016-03-24 Sunovion Pharmaceuticals Inc. Tricyclic derivative
US20160083400A1 (en) 2014-09-18 2016-03-24 Sunovion Pharmaceuticals Inc. Tricyclic guanidine derivative
US20160083391A1 (en) 2014-09-18 2016-03-24 Sunovion Pharmaceuticals Inc. Tricyclic piperazine derivative
TW201629064A (zh) 2014-10-10 2016-08-16 Ｈ 朗德貝克公司 作爲ｐｄｅ１抑制劑之三唑並吡酮
TW201639851A (zh) 2015-03-16 2016-11-16 大日本住友製藥股份有限公司 雙環咪唑衍生物
TW201643167A (zh) 2015-04-22 2016-12-16 Ｈ 朗德貝克公司 作爲ｐｄｅ１抑制劑之咪唑並三酮
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
TWI609870B (zh) 2016-02-12 2018-01-01 美國禮來大藥廠 Pde1抑制劑
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商Ｈ 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
JP2018076285A (ja) 2016-09-14 2018-05-17 大日本住友製薬株式会社 二環性イミダゾロ誘導体を含む医薬
WO2018073251A1 (en) 2016-10-18 2018-04-26 H. Lundbeck A/S Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as pde1 inhibitors
AU2017350473A1 (en) 2016-10-28 2019-04-18 H. Lundbeck A/S Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders
WO2018078042A1 (en) 2016-10-28 2018-05-03 H. Lundbeck A/S Combination treatments comprising administration of imidazopyrazinones

Similar Documents

Publication Publication Date Title
JP2019517996A5 (https=)
RU2018133391A (ru) 1,5-дигидро-4н-пиразоло[3,4-d]пиримидин-4-оны и 1,5-дигидро-4н-пиразоло[4,3-c]пиридин-4-оны в качестве ингибиторов pde1
JP6847844B2 (ja) 治療用ピリダジン化合物およびその使用
US10150767B2 (en) Therapeutic compounds and uses thereof
AU2024287194A1 (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3kd related disorders
US10155764B2 (en) Therapeutic compounds and uses thereof
AU2012299080B2 (en) Pyrimidine PDE10 inhibitors
JP2018514552A5 (https=)
JP2016503785A5 (https=)
HRP20200556T1 (hr) Novi (hetero) aril-supstituirani-piperidinil derivati, postupak za njihovu pripravu i farmaceutski pripravci koji ih sadrže
WO2016077375A1 (en) Bromodomain inhibitors and uses thereof
CN105732637B (zh) 杂芳化合物及其在药物中的应用
JP2016537384A5 (https=)
JP6814730B2 (ja) 治療用化合物およびその使用
JP2017510576A5 (https=)
JP2018529731A5 (https=)
JP2013515729A5 (https=)
CN106132956A (zh) 一类杂环化合物、其制备方法和用途
HRP20191180T1 (hr) Imidazopirazinoni kao inhibitori pde1
RU2014109748A (ru) Морфолино-замещенные производные бициклических пиримидинмочевины или карбамата в качестве ингибиторов mtor
JP2019505595A5 (https=)
PE20090944A1 (es) PIRIMIDINAS BICICLICAS FUSIONADAS COMO INHIBIDORES DE LA VIA Pi3K/AKT
JP2015528018A5 (https=)
JP2014510147A5 (https=)
RU2019108717A (ru) Комбинированные средства для лечения, предусматривающего введение имидазопиразинонов